EVENITY has been studied for its potential to reduce the risk of fractures in an extensive global Phase 3 program that included two large fracture trials comparing EVENITY to either placebo or active ...

THOUSAND OAKS, Calif., April 15, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that EVENITY™ (romosozumab-aqqg) is now available for shipment to wholesalers in the U.S. EVENITY was ...

Evenity, used to treat osteoporosis, has a boxed warning from the FDA due to increased risk of stroke, heart attack, and cardiovascular death. It’s important to promptly report symptoms like chest ...

Amgen and UCB have suffered another setback as they try to build momentum for Evenity, their new antibody therapy for osteoporosis. The EMA’s Committee for Medicinal Products for Human Use (CHMP) has ...

Doctors prescribe Evenity (romosozumab-aqqg) for treating postmenopausal osteoporosis. The drug falls under Medicare Part B coverage because a healthcare professional must administer the injection. As ...

UCB and Amgen have brought their bone-boosting drug Evenity back to US regulators for review, following an initial rejection in July last year. UCB and Amgen have brought their bone-boosting drug ...

Dear Dr. Roach: My primary care doctor has prescribed the medication Evenity for my osteoporosis. I have been on Fosamax for about three years, but my recent bone density scan went down slightly in ...